An experimental treatment that uses tiny pieces of RNA to switch off an inflammation-related gene has been tested in people for the first time.
The inhaled drug, called ARO-RAGE, is designed to reduce the activity of RAGE, a receptor found on cells lining the lungs that can help set off inflammatory responses.